Strata Critical Medical, Inc. (SRTA) Stock Forecast & Price Target
Strata Critical Medical, Inc. · NASDAQ
$5.13+0.10 (+1.88%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Strata Critical Medical, Inc, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $8.00 to $8.00, so the covering firms are broadly aligned. The average target of $8.00 sits 56% above the current $5.13. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.03 next quarter toward $-0.01 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Strata Critical Medical, Inc.
As of Jul, 3 of 3 firms rate SRTA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SRTA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.03
Range $-0.03 – $-0.03 · 1 analysts
Next period, 1 analysts expect Strata Critical Medical, Inc. to earn $-0.03 a share (range $-0.03 – $-0.03), versus — a year earlier. Full-year consensus is $-0.14, growing to $-0.01 the year after.
REVENUE · NEXT QUARTER
$69.4M
Range $68.1M – $71.2M · 1 analysts · +41% YoY
Revenue is expected to reach $69.4M (range $68.1M – $71.2M), +40.8% year-over-year. Full-year consensus is $274.3M, rising to $303.6M next year.
Top analysts covering Strata Critical Medical, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SRTA.
#1
Ben Klieve
Lake Street · Rank #333
Buy
$7.25+41.2% to target
Overall win rate
28%
+ Follow
#2
YZ
Yuan Zhi
B. Riley Securities
Buy
$8.00+55.8% to target
Coverage
—
+ Follow
#3
BB
Bill Bonello
Craig-Hallum
Buy
$8.00+55.8% to target
Coverage
—
+ Follow
#4
BH
Benjamin Haynor
Lake Street
Buy
$8.00+55.8% to target
Coverage
—
+ Follow
#5
BK
Ben Klieve
Benchmark Co.
Buy
$7.25+41.2% to target
Coverage
—
+ Follow
SRTA stock forecast FAQ
What is SRTA's average 12-month price target?+
The 3 analysts with a live target average $8.00 for Strata Critical Medical, Inc. over the next 12 months, ranging from a $8.00 high to a $8.00 low.
Is SRTA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover SRTA?+
3 analysts have an active rating on Strata Critical Medical, Inc., and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering SRTA?+
Among analysts who currently cover SRTA, Ben Klieve of Lake Street has the strongest overall Quantellect track record (Rank #333). Their current call is Buy with a $7.25 target.
What is Strata Critical Medical, Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.03 per share (range $-0.03 – $-0.03) across 1 analysts. Full-year EPS is projected at $-0.14, rising to $-0.01 the following year.
How much revenue is Strata Critical Medical, Inc. expected to report next quarter?+
Consensus revenue is $69.4M (range $68.1M – $71.2M). Full-year revenue is projected at $274.3M, growing to $303.6M next year.
Have analysts been upgrading or downgrading SRTA lately?+
As of Jul, 3 of 3 firms rate SRTA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SRTA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
